Abstract
Widespread evidence supports the existence of an endogenous digitalis- like compound in mammals. We report here the development of a novel enzyme immunonssay for ouabain that, in conjunction with a detailed HPLC study, identifies a ouabain-like compound (OLC) in extracted human plasma. The assay is sensitive-minimum detection limit for OLC 37 pmol/L (11 pmol/L in plasma)- and has a working range (between-assay CV <10%) of 180-10000 pmol/L (54-3000 pmol/L in plasma). Mean recoveries of ouabain added to plasma ranged from 90% to 100%, and plasma extracts diluted in parallel to the standard curve. Plasma OLC concentrations in 10 healthy volunteers averaged 92 pmol/L (range 55-168), assuming 100% cross-reactivity of OLC in the ouabain assay. HPLC analysis with two distinct chromatographic conditions demonstrated that endogenous human plasma OLC co-eluted with authentic ouabain. The enzyme immunoassay is rapid and easy to perform and will support further investigation of the nature of this controversial endogenous steroid.
Author supplied keywords
Cite
CITATION STYLE
Harwood, S., Little, J. A., Gallacher, G., Perrett, D., Edwards, R., & Dawnay, A. (1997). Development of enzyme immunoassay for endogenous ouabain-like compound in human plasma. Clinical Chemistry, 43(5), 715–722. https://doi.org/10.1093/clinchem/43.5.715
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.